NxStage Medical Cash Flow - Quarterly (NASDAQ:NXTM)

Add to My Stocks
$27.99 $0.42 (1.52%) NXTM stock closing price Oct 12, 2018 (Closing)

The financial analysis of NXTM requires an investor to check the cash flows for NxStage Medical. While its important to look at the NxStage Medical debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as NxStage Medical revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the NxStage Medical stock analysis. NxStage Medical generated $12.88M cash from operating activities till this quarter of 2018 Q2. NxStage Medical has a positive cash and cash equivalents change of $11.35M.

View and download details of NxStage Medical cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Net Income Cash Flow
-4.01M-1.79M-15.32M-13.01M-4.12M-1.54M-7.31M-4.89M-4M
Depreciation Depletion Amortization Cash-Flow16.94M8.3M33.75M25.32M16.83M8.46M32.63M23.97M15.64M
Net Increase (Decrease) in Assets Liabilities-6.23M-10.49M-27.29M-20.18M-18.02M-16.17M-33.29M-20.88M-13.31M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net6.19M3.11M13.66M9.86M5.11M1.95M12.56M6.8M4.83M
Net Cash from (used by) Operating Activities
12.88M-0.86M4.8M1.98M-0.19M-7.29M4.58M4.99M3.16M
Increase (Decrease) in Prop Plant And Equipment-2.24M-1.09M-9.19M-7.55M-4.93M-1.6M-8.84M-6.79M-5.46M
Acquisition Disposition of Subsidiaires---0.1M-0.1M---0.51M-0.51M-0.51M
Increase (Decrease) in Investments---2.5M-2.5M-----
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
-2.24M-1.09M-11.79M-10.15M-4.93M-1.6M-9.36M-7.3M-5.97M
Issuance (Purchase) of Equity Shares1.65M-0.26M12M11.01M8.12M4.74M5.99M3.67M1.89M
Issuance (Repayment) of Debt Securities-0.83M-0.41M-1.01M-0.65M-0.77M-0.41M-1.97M-1.37M-0.95M
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities------1.25M1.21M-
Net Cash from (used by) Financing Activities
--0.68M10.98M10.36M7.34M4.32M5.27M3.5M1.91M
Effect of Exchange Rate Changes on Cash-0.1M-1.3M1.14M-----
Net Change in Cash & Cash Equivalents
11.35M-2.3M5.29M3.34M3.2M-4.17M-1.75M-0.6M
Cash & Equivalents at Beginning of Year59.63M59.06M52.88M84.13M106.43M102.9M104.33M21.72M26.64M
Cash & Equivalents at Year End76.28M62.61M64.92M62.97M62.83M55.45M59.63M60.81M58.45M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

NxStage Medical stock price history provides insight into historical stock price fluctuations, and NxStage Medical stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • NxStage Medical had a Net Change in Cash and Cash Equivalents of $11.35M in the latest quarter 2018 Q2. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the NxStage Medical stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $12.88M for NXTM.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-2.24M for NXTM till last quarter 2018 Q2 report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $- for NxStage Medical. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For NxStage Medical Cash Flow